ClinicalTrials.Veeva

Menu

Reminiscence Therapy in Individuals With Dementia

A

Amasya University

Status

Completed

Conditions

Dementia

Treatments

Other: Reminiscence therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT06180694
amasyau-mçy-001

Details and patient eligibility

About

This research will be carried out with the aim of determining the effect of reminiscence therapy applied to individuals with dementia on cognitive functions, anxiety, depression and activities of daily living.

The research will be conducted with a pre-test post-test single group, quasi-experimental research design.

Full description

Dementia; It is a disease that requires intensive use of health services, has a high care burden, and has medical, social, psychological and economic burdens for the patient, family and society. Dementia is characterized by many disorders in cognitive functions, especially memory, thought and social skills. Progressive disorders in cognitive functions cause behavioral changes, decrease in activities of daily living, and neuropsychiatric symptoms such as anxiety and depression.

Enrollment

28 patients

Sex

All

Ages

65 to 100 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Being diagnosed with mild to moderate dementia according to DSM-5 criteria (whether individuals have an official diagnosis of neurocognitive disorder according to DSM-5 criteria and their medical diagnosis will be verified from the health records at the institution),
  • Getting a score between 13-23 for the educated (literate) and 10-23 for the uneducated (illiterate) on the mini mental state examination,
  • Being 65 years of age or older,
  • Being able to communicate,
  • No vision or hearing problems,
  • Consent to participate in the research.

Exclusion criteria

  • Getting a score below 13 and above 23 for the educated (literate) and below 10 and above 23 for the uneducated (illiterate) from the mini mental state examination,
  • Having an acute illness that prevents participation in intervention sessions,
  • Having serious sensory and physical limitations that prevent participation,
  • Having severe neuropsychiatric symptoms (agitation, psychosis, apathy, uncontrolled delirium, etc.),
  • Having a traumatic life history,
  • Having recently participated in a similar program.

Trial design

Primary purpose

Supportive Care

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

28 participants in 1 patient group

Reminiscence group
Experimental group
Description:
Reminiscence therapies will be applied to individuals with dementia
Treatment:
Other: Reminiscence therapy

Trial contacts and locations

1

Loading...

Central trial contact

çayır yılmaz

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems